Light Mode
$1.97 ↓ -0.09 (-4.37%) Trading Down from the previous close of $2.06, and at the day’s high of $1.97
+0.43 (+27.92%) / 6M
Momentum, market sentiment, and recent alerts
HRGN reads n/a: the 12-month move is +8.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.